Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 293 followers

Latest posts

Last updated about 12 hours ago

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 13, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation...

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation...

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 10, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date...

Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of authorisation: 18/08/2021, Revision: 13, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of...

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation...

Quick guide to competing interests for EMA experts

about 14 hours ago

Quick guide to competing interests for EMA experts

Article 57 product data

about 14 hours ago

Article 57 product data

Website outages and upgrades

about 14 hours ago

Website outages and upgrades

Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 19, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation...